Interview with Adial Pharmaceuticals CEO Bill Stilley
Manage episode 330487767 series 2793637
Adial Pharmaceuticals CEO Bill Stilley is leading the development of a genetically targeted therapeutic agent for alcohol use disorder. Adial is currently completing a Phase III trial to determine whether this oral medication can reduce overall alcohol use and the number of heavy drinking days.
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.
185 επεισόδια